Skip to content
Search

Latest Stories

Follow Us:
Top Stories

There is no magic pill for postpartum depression

There is no magic pill for postpartum depression
Getty Images

Priya Iyer is the founder of Our Roots, a non-profit that virtually connects BIPOC, low-income pregnant and postpartum communities to peer support coaches to prevent perinatal anxiety and depression. She holds an MPH in Epidemiology from Columbia University, and she is a Public Voices Fellow with the OpEd Project in partnership with the National Black Child Development Institute.

The FDA recently approved the first oral drug for postpartum depression, Zurzuvae. At first glance, this seems like especially good news for women and birthing people of color, who are twice as likely to experience perinatal mood disorders as compared to White women (further compounded if they are low-income). However, supporting people with perinatal depression is much more complex than popping a pill. A drug cannot replace or mask the systemic issues faced by those who need support the most.


We should stop overhyping Zurzuvae’s potential impact, when it may be inaccessible to those it is supposed to benefit. Like many other patented drugs, the cost will be potentially prohibitive. Additionally, BIPOC communities are often misdiagnosed or underdiagnosed for postpartum depression by the same clinicians whom we are relying on to prescribe the pill. This is due to a range of reasons from limited provider training on culturally-responsive care to implicit biases. An abundance of evidence shows us potential pathways to addressing disparities in health.

Yet, the U.S. healthcare system promotes profit for pharmaceutical companies over investment in proven solutions, which comes at a cost. For each mother-baby pair affected by and untreated for a perinatal mood disorder, the financial toll for society is $31,800. Sage Therapeutic (the maker of Zurzuvae) has said the price for the drug will be around $10,000. With their estimate that 400,000 people are impacted by postpartum depression, the cost of treating these birthing people each year is $4,000,000,000 to payers, which includes a projected, handsome $1.35 billion revenue stream for Sage by 2032.

At half the amount, we could offer preventative solutions to all four million people giving birth each year, including some tailored to BIPOC and low-income communities. As the founder of Our Roots, a social enterprise that connects BIPOC, low-income birthing people to peer support coaches who share lived experiences, we are able to prevent depression and anxiety at the cost of $500 per mother baby pair, and likely much less on a larger scale. These preventative and systemic fixes are far more likely to benefit those who need access the most as well as the general population.

I’ve worked as a part of an access solution program at a pharmaceutical company and have seen when underinsured or uninsured people are desperately in need of medication because preventative solutions have failed them. Pharmaceutical companies claim they will make Zurzuvae available through such access programs. However, in my experience, access programs serve primarily as marketing and branding opportunities for pharmaceutical companies. They serve as a patchwork solution without addressing the root problem of prohibitively and unnecessarily high drug costs ( 3.44 times the amount of brand-named drugs in comparable nations).

As both a BIPOC mother of two—who experienced a perinatal mood disorder—and a maternal and child health epidemiologist, I know that a combination of culturally-responsive doctors, therapists, and extensive group and individual peer and community support has been proven to both prevent and treat perinatal mood disorders. There is no magic pill that can dismantle the systems of oppression that exist in our healthcare systems and instead build systems truly tailored to the diverse fabric of our society. While systemic injustice continues to exist, we should ask ourselves who Zurzuvae will truly benefit.


Read More

President Donald Trump

President Donald Trump delivers remarks during a ceremony in honor of Veterans Day at Arlington National Cemetery on Nov. 11, 2026 in Arlington, Virginia.

(Kevin Dietsch/Getty Images/TCA)

Voters said ‘enough,’ MAGA didn’t hear

After suffering an absolute drubbing in the midterm elections, Republicans seem to have learned few lessons.

America was not subtle or ambiguous in its rebuke of President Trump, MAGA, and Republicans — no fewer than 30 incumbent House Republicans lost their seats, Senate Republicans lost eight seats, and five states changed party control at the gubernatorial level, all to Dems. It was a bloodbath.

Keep ReadingShow less
Written on a whiteboard: AI?
The letters AI and a question mark written in black marker on a whiteboard

A Democracy That Uses AI Agents Needs Permission Receipts

An organization can correct a faulty AI-generated paragraph in minutes. Repairing the damage after an automated system impersonates a trusted source, emails thousands of people, or changes public records can take much longer. As AI tools gain permission to act, civic institutions need to govern the authority they delegate with the same seriousness they give to the accuracy of an answer.

On October 8, OpenAI reported disrupting covert influence operations linked to Iran and Russia. One operation used seven fabricated journalist identities to place material in outside publications. OpenAI investigators identified almost 100 articles published or syndicated under those bylines across roughly a dozen outlets. The operators were humans using AI to refine articles and pitches. That distinction matters: this was deceptive human direction amplified by technology, rather than evidence of independent machine intentions.

Keep ReadingShow less
United States one hundred dollar bill
A close-up of Benjamin Franklin on a United States one hundred dollar bill
Photo by Adam Nir on Unsplash

Get Ahead of The Next Southern Century

When JPMorgan Chase opened a 6,500-person campus outside Dallas, it wasn't chasing cheap rent. It saw the beginning of opportunity. The bank now employs more people in Texas, about 32,000, than in New York State, where its headquarters still sits. The Park Avenue tower isn't moving but the company's center of gravity already has.

That's the part of the Southern boom narrative most business leaders still misread. The question was never whether it's happening. The question is how long the window will remain open. The South's advantages are concrete, finite, and being consumed in real time. The AI build-out pouring hundreds of billions into Texas and Georgia is straining grids never designed for it. Water, not taxes, is becoming the binding constraint of the decade. The reapportionment that will hand the region outsized political clout doesn't arrive until 2030—but the land, power contracts, and talent pipelines that decide the winners are being locked in this year. Companies treating the South as a bet they can make at leisure are already arriving late.

Keep ReadingShow less
Pacific heights , San Francisco, CA

High view over Pacific heights and San Francisco Bay at sunset

Getty Images

Class A for Residents, Class B for Investors

Neighborhood residents should be able to build ownership without surrendering control to whoever brings the largest check. I propose a neighborhood corporation with Class A shares for residents and Class B shares for outside investors. Pacific Heights and Cow Hollow could examine the first model, then make its documents and lessons available to other neighborhoods.

The distinction must mean something. Class A would protect resident governance. Class B would let outside capital participate on disclosed economic terms. The corporation would own assets it voluntarily acquires and operate agreed services. It would govern those assets and contracts; government authority over zoning, taxes and public streets would remain subject to public law.

Keep ReadingShow less